Skip to main content

£6.7 million investment to ‘harness’ the power of NHS patient data and develop targeted care

Barts Life Sciences – a partnership between Queen Mary University of London and Barts Health NHS Trust – has been awarded £6.7m by Barts Charity to research new ways to improve the prevention, diagnosis and treatment of a variety of diseases. The diseases that will be studied include COVID-19, cancer, heart disease and diabetes, which affect many in the east London population.

Published on:
Back to top